Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy

NCT04591431 is registered in ClinicalTrials.gov with Fondazione per la Medicina Personalizzata as lead sponsor.

NCT NCT04591431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04591431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy
Lead sponsor
Fondazione per la Medicina Personalizzata
Phase
Phase 2
Overall status
Unknown status
Start date
October 7, 2020
Completion date
June 30, 2025
Enrollment
400 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, gastrointestinal cancer, non small cell lung cancer, other cancer